GGrantIndex
← Leaderboards

Jeffrey M Bethony

Southwest Foundation For Biomedical Res

$12,080,724
Attributed
$26,725,759
Total exposure
5
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.3M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$26,725,759 · 5

By mechanism

UM1$19,216,523 · 1
U01$3,617,673 · 1
R01$2,717,588 · 1
K01$612,225 · 1
R56$561,750 · 1

Most similar at Southwest Foundation For Biomedical Res

Same institution · by research overlap

Others in their field

Top investigators on “Infection

Research focus

InfectionSamplingTechnologyIncidenceLinkPersonsProgramsBrazilTissue SampleSuccessComplexTumor TissueClinical ResearchSiteMalignant NeoplasmsPathogenesisFlow CytometryBaseParasitesInvestigationInnovationFreezingPrevalenceRisk Factors

Grant awards (27)

AIDS and Cancer Specimen Resource (ACSR)$3,963,281
UM1 · FY2025 · CA · contact PI
AIDS and Cancer Specimen Resource (ACSR)$456,101
UM1 · FY2025 · CA · contact PI
AIDS and Cancer Specimen Resource (ACSR)$411,640
UM1 · FY2025 · CA · contact PI
AIDS and Cancer Specimen Resource (ACSR)$4,723,702
UM1 · FY2024 · CA · contact PI
AIDS and Cancer Specimen Resource (ACSR)$4,831,082
UM1 · FY2023 · CA · contact PI
AIDS and Cancer Specimen Resource (ACSR)$4,830,717
UM1 · FY2022 · CA · contact PI
Controlled Infection Trial to Test Efficacy of Hookworm Vaccine with Different TLR Agonists$480,908
U01 · FY2022 · AI
Controlled Infection Trial to Test Efficacy of Hookworm Vaccine with Different TLR Agonists$731,524
U01 · FY2020 · AI
Controlled Infection Trial to Test Efficacy of Hookworm Vaccine with Different TLR Agonists$752,220
U01 · FY2019 · AI
Controlled Infection Trial to Test Efficacy of Hookworm Vaccine with Different TLR Agonists$855,527
U01 · FY2018 · AI
Controlled Infection Trial to Test Efficacy of Hookworm Vaccine with Different TLR Agonists$797,494
U01 · FY2017 · AI
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma$505,725
R01 · FY2015 · CA
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma$493,077
R01 · FY2014 · CA
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma$67,719
R01 · FY2014 · CA
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma$490,037
R01 · FY2013 · CA
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma$68,569
R01 · FY2013 · CA
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma$521,314
R01 · FY2012 · CA
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma$571,147
R01 · FY2011 · CA
PRODUCT DEVELOPMENT OF A MEMBRANE TETRASPANIN VACCINE AGAINST SCHISTOSOMIASIS$561,750
R56 · FY2011 · AI
Host Genetic Correlates of Helminthic Coinfection$102,629
K01 · FY2005 · TW
Host Genetic Correlates of Helminthic Coinfection$102,629
K01 · FY2004 · TW
Host Genetic Correlates of Helminthic Coinfection$102,629
K01 · FY2003 · TW
INTERNATIONAL RESEARCH SCIENTIST DEVELOPEMENT AWARD$126,483
K01 · FY2002 · TW
INTERNATIONAL RESEARCH SCIENTIST DEVELOPEMENT AWARD$45,600
K01 · FY2001 · TW
INTERNATIONAL RESEARCH SCIENTIST DEVELOPEMENT AWARD$30,000
K01 · FY2001 · TW
INTERNATIONAL RESEARCH SCINTIST DEVELOPEMENT AWARD$75,255
K01 · FY2000 · TW
INTERNATIONAL RESEARCH SCIENTIST DEVELOPEMENT AWARD$27,000
K01 · FY2000 · TW